Article
Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 Nov 2023
Xu Yuqiu, Wang Guiying, Zheng Xuzhi, Chang Wenju, Fu Jihong, Zhang Tao, Lin Qi, Lv Yang, Zhu Zhehui, Tang Wentao, Xu Jianmin
Abstract excerpt
BACKGROUND: BRAF V600E mutant-metastatic colorectal cancer (mCRC) is characterized by its short survival time. Treatment approaches vary depending on whether or not the metastases are initially resectable. The benefit of metastasectomy remains unclear, and the optimal first-line treatment is controversial. This study aimed to describe the prognosis of BRAF V600E mutant-mCRC, analyze the recurrence pattern in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
